PDSB
PDS Biotechnology Corp
NASDAQ: PDSB · HEALTHCARE · BIOTECHNOLOGY
$0.97
+1.32% today
Updated 2026-04-30
Market cap
$60.28M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$1 – $2
Volume
0.8M
PDS Biotechnology Corp (PDSB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.25M | $-8.04M | $-9.71M | $-21.75M | $-32.19M | $-40.70M | $-33.15M | $-18.07M | $-13.15M | $-12.49M | $-25.71M | $-33.64M | $-35.03M | $-27.75B |
| Capital expenditures | $611.00 | $137000.00 | $885000.00 | $1.30M | $687000.00 | $189000.00 | $3.00 | $1.00 | $5.00 | $4.00 | $4.00 | $4.00 | $29000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $260361.00 | $1.30M | $2.90M | $5.30M | $6.40M | $7.62M | $3.18M | $452288.00 | $4.11M | $5.20M | $7.61M | $6.85M | $4.11B |
| Free cash flow | $-2.25M | $-8.18M | $-10.60M | $-23.06M | $-32.88M | $-40.89M | $-33.15M | $-18.07M | $-13.15M | $-12.49M | $-25.71M | $-33.64M | $-35.06M | $-27.75B |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | $270.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | $16.68M | — | $8.58M | — | — | — |